Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.

Leukemia research - 1 Jul 2013

Qian Jun, Lin Jiang, Qian Wei, Ma Ji-chun, Qian Si-xuan, Li Yun, Yang Jing, Li Jian-yong, Wang Cui-zhu, Chai Hai-yan, Chen Xing-xing, Deng Zhao-qun

Abstract excerpt

MicroRNA miR-378 plays important roles in tumorigenesis by enhancing cell survival, reducing apoptosis, promoting tumor growth, angiogenesis and promoting cell migration and invasion. Abnormal expression of miR-378 has been observed in various types of cancers. The aim of this study was to investigate the expression status of miR-378 and its clinical significance in patients with acute myeloid leukemia (AML)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Follow-Up Studies
Share to Gene Expression Regulation, Leukemic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to MicroRNAs

Share to Nucleophosmin

Share to Oligonucleotide Array Sequence Analysis

Share to Real-Time Polymerase Chain Reaction

Share to Survival Rate

Source

Identifiers

PMID: 23582927
DOI: 10.1016/j.leukres.2013.03.014

Genes

FLT3
IDH1
IDH2
KIT
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.PMID 23582927Read ↗

MicroRNA ‐based therapies: Revolutionizing the treatment of acute myeloid leukemiaSemantic proximity Read ↗

miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromesSemantic proximity Read ↗

MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid LeukemiaSemantic proximity Read ↗

OncomiR or antioncomiR: Role of miRNAs in Acute Myeloid Leukemia.Semantic proximity Read ↗

Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.Semantic proximity Read ↗

Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia SurvivalSemantic proximity Read ↗

Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.Semantic proximity Read ↗

Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21).Semantic proximity Read ↗

Differential expression of specific microRNA and their targets in acute myeloid leukemia.Semantic proximity Read ↗

[Expression characteristics and prognosis significance of miRNA-181a in acute myeloid leukemia with normal karyotype].Semantic proximity Read ↗

KDM4C contributes to cytarabine resistance in acute myeloid leukemia via regulating the miR-328-3p/CCND2 axis through MALAT1Semantic proximity Read ↗

[Correlation of MiR-34a/b/c Expression with Treatment Response and Prognosis of Elderly Patients with Acute Myeloid Leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.